On November 5, 2024, Michael May, President and CEO, CCRM, participated in a panel discussion called “’Under Attack’: Can cell and gene therapy revolutionize the rules of healthcare?” at BIO-Europe 2024. Panelists discussed the groundbreaking potential of cell and gene therapy and its potential to reshape health care.